Serum Institute defends its rights over COVISHIELD
COVISHIELD, the Astra Zeneca developed vaccine, and manufactured by Serum Institute in India to prevent Covid19, is the subject of a trademark dispute between two entities operating in the pharmaceutical trade. Cutis Biotech (Cutis), the Plaintiff, filed the suit before the Commercial Court, Pune, alleging passing off to restrain the Defendant, Serum Institute India Private Limited (Serum…